• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G filed by Tenet Healthcare Corporation

    4/22/21 4:42:24 PM ET
    $THC
    Hospital/Nursing Management
    Health Care
    Get the next $THC alert in real time by email
    SC 13G 1 brhc10023453_sc13g.htm SC 13G

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549


    SCHEDULE 13G
    Under the Securities Exchange Act of 1934
    (Amendment No. )*

    TENET HEALTHCARE CORPORATION
    (Name of Issuer)

    Common Stock, $0.05 par value per share
    (Title of Class of Securities)

    88033G407
    (CUSIP Number)

    April 21, 2021**
    (Date of Event which Requires Filing of this Statement)

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
    ☐ Rule 13d-1(b)
    ☒ Rule 13d-1(c)
    ☐ Rule 13d-1(d)

    * The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

    **The Reporting Persons initially reported their beneficial ownership of the shares of Common Stock of Tenet Healthcare Corporation on Schedule 13G, and then switched to Schedule 13D on January 7, 2016.  Pursuant to Rule 13d-1(h), the Reporting Persons are again reporting their beneficial ownership on Schedule 13G.

    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

    Continued on following pages
    Page 1 of 9 Pages
    Exhibit Index: Page 7




    SCHEDULE 13G
    Page 2 of 9

    1
    NAMES OF REPORTING PERSONS
     
     
    GLENVIEW CAPITAL MANAGEMENT, LLC
     
     
     
     
    2
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
       
    (a)☐
       
    (b)☐
     
     
    3
    SEC USE ONLY
     
     
     
     
     
     
     
    4
    CITIZENSHIP OR PLACE OF ORGANIZATION
     
     
    Delaware
     
     
     
     
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
    5
    SOLE VOTING POWER
     
     
    0
     
     
     
     
    6
    SHARED VOTING POWER
     
     
    10,645,320
     
     
     
     
    7
    SOLE DISPOSITIVE POWER
     
     
    0
     
     
     
     
    8
    SHARED DISPOSITIVE POWER
     
     
    10,645,320
     
     
     
     
    9
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     
     
    10,645,320
     
     
     
     
    10
    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
     
     
    ☐
     
     
     
     
    11
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
     
     
    9.99% (1)
     
     
     
     
    12
    TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
     
     
    OO
     
     
     
     

    (1) Based on a total of 106,471,229 Shares outstanding as of March 12, 2021, based on the Company’s annual proxy statement on Schedule 14A, filed on March 26, 2021.



    SCHEDULE 13G Page 3 of 9

    1
    NAMES OF REPORTING PERSONS
     
     
    LARRY ROBBINS
     
     
     
     
    2
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
       
    (a)☐
       
    (b)☐
     
     
    3
    SEC USE ONLY
     
     
     
     
     
     
     
    4
    CITIZENSHIP OR PLACE OF ORGANIZATION
     
     
    United States of America
     
     
     
     
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
    5
    SOLE VOTING POWER
     
     
    0
     
     
     
     
    6
    SHARED VOTING POWER
     
     
    10,645,320
     
     
     
     
    7
    SOLE DISPOSITIVE POWER
     
     
    0
     
     
     
     
    8
    SHARED DISPOSITIVE POWER
     
     
    10,645,320
     
     
     
     
    9
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     
     
    10,645,320
     
     
     
     
    10
    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
     
     
    ☐
     
     
     
     
    11
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
     
     
    9.99 (1)
     
     
     
     
    12
    TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
     
     
    IN, HC
     
     
     
     

    (1) Based on a total of 106,471,229 Shares outstanding as of March 12, 2021, based on the Company’s annual proxy statement on Schedule 14A, filed on March 26, 2021.


    CUSIP No. 88033G407
    Page 4 of 9 Pages
    Item 1(a).
    Name of Issuer:

    Tenet Healthcare Corporation (the “Issuer”)

    Item 1(b).
    Address of Issuer’s Principal Executive Offices:

    14201 Dallas Parkway, Dallas, TX 75254

    Item 2(a).
    Name of Person Filing

    This Statement is filed on behalf of each of the following persons (collectively, the “Reporting Persons”):
    i) Glenview Capital Management, LLC (“Glenview Capital Management”); and
    ii) Larry Robbins (“Mr. Robbins”).

    This Statement relates to Shares (as defined herein) held for the accounts of Glenview Capital Partners, L.P., a Delaware limited partnership (“Glenview Capital Partners”), Glenview Capital Master Fund, Ltd., a Cayman Islands exempted company (“Glenview Capital Master Fund”), Glenview Institutional Partners, L.P., a Delaware limited partnership (“Glenview Institutional Partners”), Glenview Offshore Opportunity Master Fund, Ltd., a Cayman Islands exempted company (“Glenview Offshore Opportunity Master Fund”), and Glenview Capital Opportunity Fund, L.P., a Delaware limited partnership (“Glenview Capital Opportunity Fund” and collectively, the “Glenview Funds”).

    Glenview Capital Management serves as investment manager to each of the Glenview Funds. Mr. Robbins is the Chief Executive Officer of Glenview Capital Management.

    Item 2(b).
    Address of Principal Business Office or, if None, Residence:

    The address of the principal business office of each of Glenview Capital Management and Mr. Robbins is 767 Fifth Avenue, 44th Floor, New York, New York 10153.

    Item 2(c).
    Citizenship:

    i) Glenview Capital Management is a Delaware limited liability company;
    ii) Mr. Robbins is a citizen of the United States of America.

    Item 2(d).
    Title of Class of Securities:

    Common Stock, par value $0.05 per share (the “Shares”)

    Item 2(e).
    CUSIP Number:

    88033G407

    Item 3.
    If This Statement is Filed Pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), Check Whether the Person Filing is a:

    This Item 3 is not applicable.


    CUSIP No. 88033G407
    Page 5 of 9 Pages
    Item 4.
    Ownership:

    Item 4(a)
    Amount Beneficially Owned:

    As of April 22, 2021, Glenview Capital Management and Mr. Robbins may be deemed the beneficial owner of 10,645,320 Shares. This amount consists of: (A) 407,826 Shares held for the account of Glenview Capital Partners; (B) 2,338,955 Shares held for the account of Glenview Capital Master Fund; (C) 980,693 Shares held for the account of Glenview Institutional Partners; (D) 3,198,185 Shares held for the account of Glenview Offshore Opportunity Master Fund; and (E) 3,719,661 Shares held for the account of Glenview Capital Opportunity Fund.

    Item 4(b)
    Percent of Class:

    As of April 22, 2021, each of the Reporting Persons may be deemed the beneficial owner of approximately 9.99% of Shares outstanding. (There were 106,471,229 Shares outstanding as of March 12, 2021, based on the Company’s annual proxy statement on Schedule 14A, filed on March 26, 2021.)

    Item 4(c)
    Number of Shares as to which such person has:

    (i) Sole power to vote or direct the vote:
    0
    (ii) Shared power to vote or direct the vote:
    10,645,320
    (iii) Sole power to dispose or direct the disposition of:
    0
    (iv) Shared power to dispose or direct the disposition of:
    10,645,320

    Item 5.
    Ownership of Five Percent or Less of a Class:

    This Item 5 is not applicable.

    Item 6.
    Ownership of More than Five Percent on Behalf of Another Person:

    See disclosure in Items 2 and 4 hereof. Certain funds listed in Item 2(a) are known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the Shares covered by this Statement that may be deemed to be beneficially owned by the Reporting Persons.

    Item 7.
    Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person:

    See disclosure in Item 2 hereof.

    Item 8.
    Identification and Classification of Members of the Group:

    This Item 8 is not applicable.

    Item 9.
    Notice of Dissolution of Group:

    This Item 9 is not applicable.

    Item 10.
    Certification:

    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under §240.14a-11.


    CUSIP No. 88033G407
    Page 6 of 9 Pages
    SIGNATURE

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     
    GLENVIEW CAPITAL
    MANAGEMENT, LLC
     
           
     
    By:
    /s/ Mark J. Horowitz
     
       
    Mark J. Horowitz
     
       
    Co-President of Glenview Capital Management, LLC
     
           
     
    LARRY ROBBINS
     
           
     
    By:
    /s/ Mark J. Horowitz
     
       
    Mark J. Horowitz, attorney-in-fact for Larry Robbins
     
           
    April 22, 2021
         
     

    CUSIP No. 88033G407
    Page 7 of 9 Pages
    EXHIBIT INDEX

    Ex.
    Page No.

    A
    Joint Filing Agreement
    8
    B
    Power of Attorney
    9




    Get the next $THC alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $THC

    DatePrice TargetRatingAnalyst
    10/14/2025$224.00Buy
    Goldman
    7/28/2025Outperform → Peer Perform
    Wolfe Research
    5/29/2025$195.00Equal Weight → Overweight
    Wells Fargo
    4/15/2025$137.00Outperform → Neutral
    Robert W. Baird
    3/26/2025$165.00Overweight
    Morgan Stanley
    2/26/2025$175.00Buy
    TD Cowen
    12/17/2024$175.00Overweight
    Analyst
    12/16/2024$196.00 → $140.00Buy → Neutral
    Goldman
    More analyst ratings

    $THC
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by Tenet Healthcare Corporation

    SCHEDULE 13G/A - TENET HEALTHCARE CORP (0000070318) (Subject)

    3/27/26 1:35:42 PM ET
    $THC
    Hospital/Nursing Management
    Health Care

    SEC Form 144 filed by Tenet Healthcare Corporation

    144 - TENET HEALTHCARE CORP (0000070318) (Subject)

    3/9/26 1:08:26 PM ET
    $THC
    Hospital/Nursing Management
    Health Care

    SEC Form 10-K filed by Tenet Healthcare Corporation

    10-K - TENET HEALTHCARE CORP (0000070318) (Filer)

    2/17/26 4:05:49 PM ET
    $THC
    Hospital/Nursing Management
    Health Care

    $THC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP, Chief Information Officer Arbour Paola M sold $1,549,795 worth of shares (6,500 units at $238.43), decreasing direct ownership by 18% to 29,291 units (SEC Form 4)

    4 - TENET HEALTHCARE CORP (0000070318) (Issuer)

    3/13/26 8:00:03 PM ET
    $THC
    Hospital/Nursing Management
    Health Care

    SEC Form 4 filed by Tenet Healthcare Corporation

    4 - TENET HEALTHCARE CORP (0000070318) (Issuer)

    3/10/26 8:00:03 PM ET
    $THC
    Hospital/Nursing Management
    Health Care

    New insider Maloney Michael T. claimed ownership of 101,990 shares (SEC Form 3)

    3 - TENET HEALTHCARE CORP (0000070318) (Issuer)

    3/9/26 8:00:04 PM ET
    $THC
    Hospital/Nursing Management
    Health Care

    $THC
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Tenet to Participate in the Barclays 28th Annual Global Healthcare Conference

    Tenet Healthcare Corporation (NYSE:THC) is scheduled to present at the Barclays 28th Annual Global Healthcare Conference on Tuesday, March 10, 2026, beginning at 9:30 a.m. Eastern Time. A live webcast and audio archive of the event may be accessed through the investor relations section of Tenet's website at www.tenethealth.com/investors. The replay will be available for 30 days. About Tenet Healthcare Tenet Healthcare Corporation (NYSE:THC) is a diversified healthcare services company headquartered in Dallas. Our care delivery network includes United Surgical Partners International, the largest ambulatory platform in the country, which operates ambulatory surgery centers and surgical

    3/4/26 9:00:00 AM ET
    $THC
    Hospital/Nursing Management
    Health Care

    Tenet Reports Strong Fourth Quarter and FY 2025 Results; Provides 2026 Financial Outlook

    Net income available to common shareholders in fourth quarter 2025 was $371 million, or $4.22 per diluted share Adjusted diluted earnings per share1 increased 36.6% to $4.70 in fourth quarter 2025 compared to $3.44 in fourth quarter 2024 Consolidated Adjusted EBITDA1 in fourth quarter 2025 increased 12.9% to $1.183 billion compared to fourth quarter 2024; Fourth quarter 2025 Adjusted EBITDA margin was 21.4% Fourth quarter 2025 Ambulatory Care Adjusted EBITDA of $580 million increased 9.4% over fourth quarter 2024 FY 2026 Adjusted EBITDA Outlook is expected to be in the range of $4.485 billion to $4.785 billion Tenet Healthcare Corporation (Tenet) (NYSE:THC) today announc

    2/11/26 6:45:00 AM ET
    $THC
    Hospital/Nursing Management
    Health Care

    Tenet Announces Accretive Transaction and Previews Strong 2025 Results

    Tenet completes transaction with CommonSpirit Health to resume full ownership of Conifer Health Solutions. Tenet Healthcare Corporation (NYSE:THC) today announced the completion of a strategic transaction with CommonSpirit Health involving Tenet's Conifer Health Solutions subsidiary. Key terms of the transaction include: Payments totaling approximately $1.9 billion from CommonSpirit to Tenet in installments over the next three years Approximately $540 million redemption payment from Conifer to CommonSpirit to address the elimination of CommonSpirit's capital account and the redemption of CommonSpirit's 23.8% equity stake in Conifer, retroactively effective January 1, 2026 Incre

    2/2/26 6:45:00 AM ET
    $THC
    Hospital/Nursing Management
    Health Care

    $THC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Goldman resumed coverage on Tenet Healthcare with a new price target

    Goldman resumed coverage of Tenet Healthcare with a rating of Buy and set a new price target of $224.00

    10/14/25 8:54:13 AM ET
    $THC
    Hospital/Nursing Management
    Health Care

    Tenet Healthcare downgraded by Wolfe Research

    Wolfe Research downgraded Tenet Healthcare from Outperform to Peer Perform

    7/28/25 8:36:14 AM ET
    $THC
    Hospital/Nursing Management
    Health Care

    Tenet Healthcare upgraded by Wells Fargo with a new price target

    Wells Fargo upgraded Tenet Healthcare from Equal Weight to Overweight and set a new price target of $195.00

    5/29/25 8:14:10 AM ET
    $THC
    Hospital/Nursing Management
    Health Care

    $THC
    Leadership Updates

    Live Leadership Updates

    View All

    Ryder System, Inc. Elects Tammy Romo to Its Board of Directors

    The board of directors of Ryder System, Inc. (NYSE:R) today announces the appointment of Tammy Romo, 63, to its board, effective January 5, 2026. Romo will serve as a member of the Audit and Finance Committees. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251219927656/en/Ryder appoints Tammy Romo to its board of directors, effective January 5, 2026. "The board nominated Tammy as a director for her impressive results-oriented leadership style, proven ability to provide strategic oversight in complex public company settings, and her deep transportation expertise," says Ryder Chairman and CEO Robert Sanchez. "Tammy's experience in

    12/19/25 6:55:00 AM ET
    $R
    $THC
    Rental/Leasing Companies
    Consumer Discretionary
    Hospital/Nursing Management
    Health Care

    Tenet Healthcare Appoints Vineeta Agarwala to Board of Directors

    Tenet Healthcare Corporation (NYSE:THC) today announced the appointment of Vineeta Agarwala, M.D., PhD, to its Board of Directors, effective immediately. Dr. Agarwala will serve as a member of the Quality, Compliance, and Ethics Committee, as well as the Human Resources Committee, increasing the size of the Board to 13 directors. "We are pleased to welcome Dr. Vineeta Agarwala to the Tenet Board," said Saum Sutaria, M.D., Chairman and Chief Executive Officer of Tenet. "Vineeta is a leader in healthcare in her own right. Her expertise in innovative technologies, including applications of artificial intelligence will enhance our governance in a rapidly evolving healthcare marketplace." Dr

    12/13/23 4:05:00 PM ET
    $THC
    Hospital/Nursing Management
    Health Care

    Tenet Healthcare Appoints Senator Roy Blunt to Board of Directors

    Tenet Healthcare Corporation (NYSE:THC) today announced the appointment of Senator Roy Blunt to the Tenet Board of Directors, effective immediately. Senator Blunt will serve as a member of the Audit Committee, Nominating and Corporate Governance Committee, and Environmental, Social, and Governance Committee. This appointment expands the Board to 12 directors, 11 of whom are independent members. "We are pleased to welcome Senator Roy Blunt as a new board member," said Saum Sutaria, M.D., Chief Executive Officer of Tenet. "With more than 25 years of legislative experience, Roy's expertise in public policy and addressing cross-cutting issues will be invaluable to helping Tenet make a lasting

    8/10/23 4:05:00 PM ET
    $THC
    Hospital/Nursing Management
    Health Care

    $THC
    Financials

    Live finance-specific insights

    View All

    Tenet to Report its Fourth Quarter 2025 Results on February 11th

    Tenet Healthcare Corporation (NYSE:THC) will release its fourth quarter 2025 results before the market opens on Wednesday, February 11, 2026, to be followed by a conference call at 9:00 a.m. CT (10:00 a.m. Eastern Time). A live webcast and audio archive of the call may be accessed through the investor relations section of Tenet's website at www.tenethealth.com/investors. About Tenet Healthcare Tenet Healthcare Corporation (NYSE:THC) is a diversified healthcare services company headquartered in Dallas. Our care delivery network includes United Surgical Partners International, the largest ambulatory platform in the country, which operates ambulatory surgery centers and surgical hospital

    1/7/26 9:00:00 AM ET
    $THC
    Hospital/Nursing Management
    Health Care

    Tenet to Report Its Third Quarter 2025 Results on October 28th

    Tenet Healthcare Corporation (NYSE:THC) will release its third quarter 2025 results before the market opens on Tuesday, October 28, 2025, to be followed by a conference call at 9:30 a.m. CT (10:30 a.m. Eastern Time). A live webcast and audio archive of the call may be accessed through the investor relations section of Tenet's website at www.tenethealth.com/investors. About Tenet Healthcare Tenet Healthcare Corporation (NYSE:THC) is a diversified healthcare services company headquartered in Dallas. Our care delivery network includes United Surgical Partners International, the largest ambulatory platform in the country, which operates ambulatory surgery centers and surgical hospitals. W

    9/30/25 9:00:00 AM ET
    $THC
    Hospital/Nursing Management
    Health Care

    Tenet to Report its Second Quarter 2025 Results on July 22nd

    Tenet Healthcare Corporation (NYSE:THC) will release its second quarter 2025 results before the market opens on Tuesday, July 22nd, 2025, to be followed by a conference call at 9:00 a.m. CT (10:00 a.m. Eastern Time). A live webcast and audio archive of the call may be accessed through the investor relations section of Tenet's website at www.tenethealth.com/investors. About Tenet Healthcare Tenet Healthcare Corporation (NYSE:THC) is a diversified healthcare services company headquartered in Dallas. Our care delivery network includes United Surgical Partners International, the largest ambulatory platform in the country, which operates ambulatory surgery centers and surgical hospitals. W

    6/23/25 9:00:00 AM ET
    $THC
    Hospital/Nursing Management
    Health Care

    $THC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Tenet Healthcare Corporation

    SC 13G/A - TENET HEALTHCARE CORP (0000070318) (Subject)

    11/14/24 4:17:18 PM ET
    $THC
    Hospital/Nursing Management
    Health Care

    Amendment: SEC Form SC 13G/A filed by Tenet Healthcare Corporation

    SC 13G/A - TENET HEALTHCARE CORP (0000070318) (Subject)

    11/14/24 1:22:34 PM ET
    $THC
    Hospital/Nursing Management
    Health Care

    SEC Form SC 13G filed by Tenet Healthcare Corporation

    SC 13G - TENET HEALTHCARE CORP (0000070318) (Subject)

    11/12/24 10:34:15 AM ET
    $THC
    Hospital/Nursing Management
    Health Care